Related Experiment Video

Updated: Aug 11, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Postmyocardial infarction patients: experience from the SAVE trial

K F Connors1, G A Lamas

  • 1Department of Cardiology, Beth Israel Hospital, Boston, MA 02215.

American Journal of Critical Care : an Official Publication, American Association of Critical-Care Nurses
|January 1, 1995
PubMed

Insights

Captopril, an angiotensin-converting enzyme inhibitor, significantly reduces ventricular dilatation and prevents heart failure after acute myocardial infarction. This treatment improves survival rates and reduces mortality in selected patients.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Acute myocardial infarction (AMI) poses a significant threat to patient survival.
  • While current treatments reduce mortality, post-infarction ventricular remodeling, such as dilatation, predicts poor prognosis.

Purpose of the Study:

  • To review the results of the Survival and Ventricular Enlargement (SAVE) trial.
  • To present guidelines for effective captopril dosage following acute myocardial infarction.

Main Methods:

  • The study reviewed data from the Survival and Ventricular Enlargement trial.
  • Captopril was administered to selected patients 3 to 16 days after acute myocardial infarction.

Main Results:

  • Captopril administration reduced ventricular dilatation.
  • It prevented the development of congestive heart failure.
  • Morbidity and mortality were significantly reduced in the treated group.

Conclusions:

  • Captopril is an effective treatment for selected patients post-acute myocardial infarction.
  • Early intervention with captopril can mitigate adverse cardiac remodeling and improve long-term outcomes.
  • Guidelines for captopril dosage are provided to optimize its use in this patient population.

More Related Videos

Myocardial Infarction and Functional Outcome Assessment in Pigs12:03

Myocardial Infarction and Functional Outcome Assessment in Pigs

Published on: April 25, 2014

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction14:19

Primary Outcome Assessment in a Pig Model of Acute Myocardial Infarction

Published on: October 14, 2016

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...